ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,308.15
1.17%
US Tech 100
18,155.60
0.22%
다우존스 지수
39,908.00
0.88%
Bitcoin
66,325.52
0.10%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Virpax Pharmaceuticals Inc (VRPX)

  7. Virpax Pharmaceuticals Inc (VRPX) 뉴스

VRPX Virpax Pharmaceuticals Inc

0.7994
0.0194 (2.49%)
시간외 단일가
최종 업데이트: 17:02:11
15분 지연
기업명 주식 심볼 시장 주식 타입
Virpax Pharmaceuticals Inc VRPX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0194 2.49% 0.7994 17:02:11
개장가 저가 고가 종가 전일 종가
0.78
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/05/202421:00BWVirpax Announces Pricing of $2.25 Million Public Offering
15/05/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
14/05/202406:30EDGAR2Form S-1/A - General form for registration of securities..
14/05/202405:20EDGAR2Form 8-K - Current report
14/05/202405:10BWVirpax Pharmaceuticals Reports 2024 First Quarter Results..
14/05/202405:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/04/202420:30BWVirpax Announces Results of Maximum Tolerated Dose Study for..
26/03/202420:30BWVirpax Pharmaceuticals Reports 2023 Year-End Results
27/02/202421:31BWVirpax Pharmaceuticals Announces Reverse Stock Split to..
27/02/202421:30BWVirpax Pharmaceuticals Announces Proposed Settlement of..
07/02/202421:30BWVirpax Pharmaceuticals Announces Preliminary Results of..
01/02/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202321:30EDGAR2Form 8-K - Current report
29/12/202321:30BWVirpax Pharmaceuticals Announces Results of Special..
13/12/202322:30EDGAR2Form 8-K - Current report
07/12/202323:08EDGAR2Form DEF 14A - Other definitive proxy statements
07/12/202322:58EDGAR2Form 8-K - Current report
07/12/202322:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/11/202306:57EDGAR2Form PRE 14A - Other preliminary proxy statements
17/11/202321:30EDGAR2Form 8-K - Current report
17/11/202321:15EDGAR2Form 8-K - Current report
17/11/202321:10BWVirpax Pharmaceuticals Announces Notification from Nasdaq..
17/11/202321:00BW Virpax Pharmaceuticals Announces Leadership Transition
17/11/202306:51EDGAR2Form 8-K - Current report
16/11/202306:15BWVirpax Pharmaceuticals Reports 2023 Third Quarter Results..
16/11/202305:03EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
31/10/202321:58BWVirpax Pharmaceuticals Announces that Envelta™ Remains on..
12/10/202321:02BWVirpax Pharmaceuticals Announces Extension of CRADA with the..
12/10/202305:10EDGAR2Form 8-K - Current report
03/10/202322:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202321:58BWGerald W. Bruce Appointed President and CEO of Novvae™..
27/09/202321:58BWVirpax Pharmaceuticals Announces Results of Probudur™ Dose..
26/09/202321:58BWVirpax Pharmaceuticals to Present at the LD Micro Main Event..
22/09/202302:35BWAltasciences von Virpax ausgewählt, um die Entwicklung eines..
22/09/202302:18BWAltasciences choisi par Virpax pour soutenir le..
21/09/202323:00BWAltasciences Chosen by Virpax to Support the Development of..
18/09/202320:58BWVirpax Pharmaceuticals Announces the Formation of Novvae™..
05/09/202322:28EDGAR2Form 8-K - Current report
05/09/202322:00BWVirpax Pharmaceuticals Updates on Litigation
28/08/202321:58BWVirpax® Pharmaceuticals to Present at H.C. Wainwright 25th..
17/08/202306:00EDGAR2Form 8-K - Current report
14/08/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202322:05EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
VRPX
Virpax Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유